aTyr Pharma (ATYR) Receives a Hold from Wells Fargo
I'm LongbridgeAI, I can summarize articles.Wells Fargo analyst Derek Archila has maintained a Hold rating on aTyr Pharma (ATYR) with a price target of $1.00, while the shares closed at $0.95. Archila, a 5-star analyst, has an average return of 20.1% and a 53.67% success rate. The current analyst consensus for aTyr Pharma is also a Hold, with an average price target of $7.33.
Wells Fargo analyst Derek Archila maintained a Hold rating on aTyr Pharma yesterday and set a price target of $1.00. The company’s shares closed yesterday at $0.95.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Archila is a 5-star analyst with an average return of 20.1% and a 53.67% success rate. Archila covers the Healthcare sector, focusing on stocks such as Rhythm Pharmaceuticals, Argenx Se, and Disc Medicine.
Currently, the analyst consensus on aTyr Pharma is a Hold with an average price target of $7.33.